{"entity":{"type":"insider","cik":"0001883840","url":"/insider/0001883840","json_url":"/insider/0001883840.json","name":"RA Capital Nexus Fund III, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":96,"n_filings":29,"first":"2023-02-16","last":"2026-08-14","span_basis":"filed_date"},"name_variants":[{"name":"RA Capital Nexus Fund III, L.P.","source":"filing","n_filings":29,"first_seen":"2023-02-16","last_seen":"2026-08-14"}],"transactions":[{"id":9276045,"accession":"0001231919-26-000938","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231919-26-000938","line_url":"/filing/0001231919-26-000938","is_derivative":false,"issuer_cik":"0001984086","issuer_name":"Septerna, Inc.","issuer_ticker":"SEPN","issuer_name_source":null,"issuer_url":"/issuer/0001984086","owner_cik":null,"owner_name":"Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; Shah Rajeev M.","owner_display_name":"Kolchinsky Peter","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1493000.0,"shares_display":"1,493,000","price_per_share":42.5,"price_display":"42.50","price_state":"stated","total_value":63452500.0,"total_display":"63,452,500.00","total_whole":"63,452,500","shares_owned_after":4777415.0,"shares_owned_after_display":"4,777,415","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-12","filed_date":"2026-08-14","scope":"insider","n_lines":2},{"id":5750630,"accession":"0001231919-26-000817","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001231919-26-000817","line_url":"/filing/0001231919-26-000817#line-2","is_derivative":false,"issuer_cik":"0001315082","issuer_name":"Artiva Biotherapeutics, Inc.","issuer_ticker":"ARTV","issuer_name_source":null,"issuer_url":"/issuer/0001315082","owner_cik":null,"owner_name":"RA Capital Nexus Fund III, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund, L.P.; Kolchinsky Peter; Shah Rajeev M.","owner_display_name":"RA Capital Nexus Fund III, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":24944.0,"shares_display":"24,944","price_per_share":9.93,"price_display":"9.93","price_state":"stated","total_value":247693.92,"total_display":"247,693.92","total_whole":"247,694","shares_owned_after":17329570.0,"shares_owned_after_display":"17,329,570","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-31","filed_date":"2026-07-31","scope":"insider"},{"id":5750628,"accession":"0001231919-26-000817","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231919-26-000817","line_url":"/filing/0001231919-26-000817#line-1","is_derivative":false,"issuer_cik":"0001315082","issuer_name":"Artiva Biotherapeutics, Inc.","issuer_ticker":"ARTV","issuer_name_source":null,"issuer_url":"/issuer/0001315082","owner_cik":null,"owner_name":"RA Capital Nexus Fund III, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund, L.P.; Kolchinsky Peter; Shah Rajeev M.","owner_display_name":"RA Capital Nexus Fund III, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20824.0,"shares_display":"20,824","price_per_share":9.99,"price_display":"9.99","price_state":"stated","total_value":208031.76,"total_display":"208,031.76","total_whole":"208,032","shares_owned_after":17304626.0,"shares_owned_after_display":"17,304,626","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-29","filed_date":"2026-07-31","scope":"insider"},{"id":5921422,"accession":"0001231919-26-000808","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231919-26-000808","line_url":"/filing/0001231919-26-000808#line-1","is_derivative":false,"issuer_cik":"0001315082","issuer_name":"Artiva Biotherapeutics, Inc.","issuer_ticker":"ARTV","issuer_name_source":null,"issuer_url":"/issuer/0001315082","owner_cik":null,"owner_name":"RA Capital Nexus Fund III, L.P.; RA Capital Nexus Fund, L.P.; Kolchinsky Peter; Shah Rajeev M.; RA Capital Healthcare Fund LP","owner_display_name":"RA Capital Nexus Fund III, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":41319.0,"shares_display":"41,319","price_per_share":9.99,"price_display":"9.99","price_state":"stated","total_value":412776.81,"total_display":"412,776.81","total_whole":"412,777","shares_owned_after":17283802.0,"shares_owned_after_display":"17,283,802","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-24","filed_date":"2026-07-28","scope":"insider"},{"id":6042465,"accession":"0001231919-26-000791","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001231919-26-000791","line_url":"/filing/0001231919-26-000791#line-3","is_derivative":false,"issuer_cik":"0001315082","issuer_name":"Artiva Biotherapeutics, Inc.","issuer_ticker":"ARTV","issuer_name_source":null,"issuer_url":"/issuer/0001315082","owner_cik":null,"owner_name":"Shah Rajeev M.; RA Capital Nexus Fund III, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund, L.P.; Kolchinsky Peter","owner_display_name":"Shah Rajeev M.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":59880.0,"shares_display":"59,880","price_per_share":9.96,"price_display":"9.96","price_state":"stated","total_value":596404.8,"total_display":"596,404.80","total_whole":"596,405","shares_owned_after":17242483.0,"shares_owned_after_display":"17,242,483","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-23","filed_date":"2026-07-23","scope":"insider"},{"id":6042458,"accession":"0001231919-26-000791","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001231919-26-000791","line_url":"/filing/0001231919-26-000791#line-2","is_derivative":false,"issuer_cik":"0001315082","issuer_name":"Artiva Biotherapeutics, Inc.","issuer_ticker":"ARTV","issuer_name_source":null,"issuer_url":"/issuer/0001315082","owner_cik":null,"owner_name":"Shah Rajeev M.; RA Capital Nexus Fund III, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund, L.P.; Kolchinsky Peter","owner_display_name":"Shah Rajeev M.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":84124.0,"shares_display":"84,124","price_per_share":9.93,"price_display":"9.93","price_state":"stated","total_value":835351.32,"total_display":"835,351.32","total_whole":"835,351","shares_owned_after":17182603.0,"shares_owned_after_display":"17,182,603","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-22","filed_date":"2026-07-23","scope":"insider"},{"id":6019489,"accession":"0001231919-26-000779","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001231919-26-000779","line_url":"/filing/0001231919-26-000779#line-6","is_derivative":false,"issuer_cik":"0001315082","issuer_name":"Parabilis Medicines, Inc.","issuer_ticker":"PBLS","issuer_name_source":null,"issuer_url":"/issuer/0001315082","owner_cik":null,"owner_name":"Kolchinsky Peter; RA Capital Healthcare Fund LP; Shah Rajeev M.; RA Capital Nexus Fund III, L.P.","owner_display_name":"Kolchinsky Peter","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Voting Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":47250.0,"shares_display":"47,250","price_per_share":29.77,"price_display":"29.77","price_state":"stated","total_value":1406632.5,"total_display":"1,406,632.50","total_whole":"1,406,633","shares_owned_after":26529686.0,"shares_owned_after_display":"26,529,686","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-22","filed_date":"2026-07-22","scope":"insider"},{"id":6042456,"accession":"0001231919-26-000791","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231919-26-000791","line_url":"/filing/0001231919-26-000791#line-1","is_derivative":false,"issuer_cik":"0001315082","issuer_name":"Artiva Biotherapeutics, Inc.","issuer_ticker":"ARTV","issuer_name_source":null,"issuer_url":"/issuer/0001315082","owner_cik":null,"owner_name":"Shah Rajeev M.; RA Capital Nexus Fund III, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund, L.P.; Kolchinsky Peter","owner_display_name":"Shah Rajeev M.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":120582.0,"shares_display":"120,582","price_per_share":9.55,"price_display":"9.55","price_state":"stated","total_value":1151558.1,"total_display":"1,151,558.10","total_whole":"1,151,558","shares_owned_after":17098479.0,"shares_owned_after_display":"17,098,479","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-21","filed_date":"2026-07-23","scope":"insider"},{"id":6019486,"accession":"0001231919-26-000779","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001231919-26-000779","line_url":"/filing/0001231919-26-000779","is_derivative":false,"issuer_cik":"0001315082","issuer_name":"Parabilis Medicines, Inc.","issuer_ticker":"PBLS","issuer_name_source":null,"issuer_url":"/issuer/0001315082","owner_cik":null,"owner_name":"Kolchinsky Peter; RA Capital Healthcare Fund LP; Shah Rajeev M.; RA Capital Nexus Fund III, L.P.","owner_display_name":"Kolchinsky Peter","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Voting Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65923.0,"shares_display":"65,923","price_per_share":29.24672481531484,"price_display":"29.25","price_state":"stated","total_value":1928031.84,"total_display":"1,928,031.84","total_whole":"1,928,032","shares_owned_after":26482436.0,"shares_owned_after_display":"26,482,436","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-21","filed_date":"2026-07-22","scope":"insider","n_lines":3},{"id":6019476,"accession":"0001231919-26-000779","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001231919-26-000779","line_url":"/filing/0001231919-26-000779","is_derivative":false,"issuer_cik":"0001315082","issuer_name":"Parabilis Medicines, Inc.","issuer_ticker":"PBLS","issuer_name_source":null,"issuer_url":"/issuer/0001315082","owner_cik":null,"owner_name":"Kolchinsky Peter; RA Capital Healthcare Fund LP; Shah Rajeev M.; RA Capital Nexus Fund III, L.P.","owner_display_name":"Kolchinsky Peter","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Voting Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":131420.0,"shares_display":"131,420","price_per_share":27.27809260386547,"price_display":"27.28","price_state":"stated","total_value":3584886.93,"total_display":"3,584,886.93","total_whole":"3,584,887","shares_owned_after":26383526.0,"shares_owned_after_display":"26,383,526","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-20","filed_date":"2026-07-22","scope":"insider","n_lines":2},{"id":5774919,"accession":"0001231919-26-000774","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001231919-26-000774","line_url":"/filing/0001231919-26-000774#line-2","is_derivative":false,"issuer_cik":"0001315082","issuer_name":"Artiva Biotherapeutics, Inc.","issuer_ticker":"ARTV","issuer_name_source":null,"issuer_url":"/issuer/0001315082","owner_cik":null,"owner_name":"Shah Rajeev M.; RA Capital Nexus Fund III, L.P.; RA Capital Nexus Fund, L.P.; Kolchinsky Peter; RA Capital Healthcare Fund LP","owner_display_name":"Shah Rajeev M.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7882.0,"shares_display":"7,882","price_per_share":8.95,"price_display":"8.95","price_state":"stated","total_value":70543.9,"total_display":"70,543.90","total_whole":"70,544","shares_owned_after":16977927.0,"shares_owned_after_display":"16,977,927","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-17","filed_date":"2026-07-20","scope":"insider"},{"id":5774917,"accession":"0001231919-26-000774","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231919-26-000774","line_url":"/filing/0001231919-26-000774#line-1","is_derivative":false,"issuer_cik":"0001315082","issuer_name":"Artiva Biotherapeutics, Inc.","issuer_ticker":"ARTV","issuer_name_source":null,"issuer_url":"/issuer/0001315082","owner_cik":null,"owner_name":"Shah Rajeev M.; RA Capital Nexus Fund III, L.P.; RA Capital Nexus Fund, L.P.; Kolchinsky Peter; RA Capital Healthcare Fund LP","owner_display_name":"Shah Rajeev M.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":152472.0,"shares_display":"152,472","price_per_share":8.93,"price_display":"8.93","price_state":"stated","total_value":1361574.96,"total_display":"1,361,574.96","total_whole":"1,361,575","shares_owned_after":16970045.0,"shares_owned_after_display":"16,970,045","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-16","filed_date":"2026-07-20","scope":"insider"},{"id":9276039,"accession":"0001231919-26-000790","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231919-26-000790","line_url":"/filing/0001231919-26-000790#line-1","is_derivative":false,"issuer_cik":"0001315082","issuer_name":"Artiva Biotherapeutics, Inc.","issuer_ticker":"ARTV","issuer_name_source":null,"issuer_url":"/issuer/0001315082","owner_cik":null,"owner_name":"Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; RA Capital Nexus Fund, L.P.; Shah Rajeev M.","owner_display_name":"Kolchinsky Peter","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6522.0,"shares_display":"6,522","price_per_share":8.94,"price_display":"8.94","price_state":"stated","total_value":58306.68,"total_display":"58,306.68","total_whole":"58,307","shares_owned_after":16817543.0,"shares_owned_after_display":"16,817,543","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-13","filed_date":"2026-07-23","scope":"insider"},{"id":6237709,"accession":"0001231919-26-000764","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001231919-26-000764","line_url":"/filing/0001231919-26-000764#line-2","is_derivative":false,"issuer_cik":"0001315082","issuer_name":"Artiva Biotherapeutics, Inc.","issuer_ticker":"ARTV","issuer_name_source":null,"issuer_url":"/issuer/0001315082","owner_cik":null,"owner_name":"Shah Rajeev M.; RA Capital Nexus Fund III, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund, L.P.; Kolchinsky Peter","owner_display_name":"Shah Rajeev M.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6552.0,"shares_display":"6,552","price_per_share":8.94,"price_display":"8.94","price_state":"stated","total_value":58574.88,"total_display":"58,574.88","total_whole":"58,575","shares_owned_after":16817573.0,"shares_owned_after_display":"16,817,573","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-13","filed_date":"2026-07-14","scope":"insider"},{"id":6237704,"accession":"0001231919-26-000764","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231919-26-000764","line_url":"/filing/0001231919-26-000764#line-1","is_derivative":false,"issuer_cik":"0001315082","issuer_name":"Artiva Biotherapeutics, Inc.","issuer_ticker":"ARTV","issuer_name_source":null,"issuer_url":"/issuer/0001315082","owner_cik":null,"owner_name":"Shah Rajeev M.; RA Capital Nexus Fund III, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund, L.P.; Kolchinsky Peter","owner_display_name":"Shah Rajeev M.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15102.0,"shares_display":"15,102","price_per_share":8.97,"price_display":"8.97","price_state":"stated","total_value":135464.94,"total_display":"135,464.94","total_whole":"135,465","shares_owned_after":16811021.0,"shares_owned_after_display":"16,811,021","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-10","filed_date":"2026-07-14","scope":"insider"},{"id":5811522,"accession":"0001231919-26-000711","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001231919-26-000711","line_url":"/filing/0001231919-26-000711#line-2","is_derivative":false,"issuer_cik":"0001315082","issuer_name":"Artiva Biotherapeutics, Inc.","issuer_ticker":"ARTV","issuer_name_source":null,"issuer_url":"/issuer/0001315082","owner_cik":null,"owner_name":"RA Capital Nexus Fund III, L.P.; Shah Rajeev M.; RA Capital Nexus Fund, L.P.; Kolchinsky Peter; RA Capital Healthcare Fund LP","owner_display_name":"RA Capital Nexus Fund III, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1876.0,"shares_display":"1,876","price_per_share":8.98,"price_display":"8.98","price_state":"stated","total_value":16846.48,"total_display":"16,846.48","total_whole":"16,846","shares_owned_after":16795919.0,"shares_owned_after_display":"16,795,919","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-26","filed_date":"2026-06-29","scope":"insider"},{"id":5811520,"accession":"0001231919-26-000711","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231919-26-000711","line_url":"/filing/0001231919-26-000711#line-1","is_derivative":false,"issuer_cik":"0001315082","issuer_name":"Artiva Biotherapeutics, Inc.","issuer_ticker":"ARTV","issuer_name_source":null,"issuer_url":"/issuer/0001315082","owner_cik":null,"owner_name":"RA Capital Nexus Fund III, L.P.; Shah Rajeev M.; RA Capital Nexus Fund, L.P.; Kolchinsky Peter; RA Capital Healthcare Fund LP","owner_display_name":"RA Capital Nexus Fund III, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":31000.0,"shares_display":"31,000","price_per_share":8.88,"price_display":"8.88","price_state":"stated","total_value":275280.0,"total_display":"275,280.00","total_whole":"275,280","shares_owned_after":16794043.0,"shares_owned_after_display":"16,794,043","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-25","filed_date":"2026-06-29","scope":"insider"},{"id":5838792,"accession":"0001231919-26-000656","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001231919-26-000656","line_url":"/filing/0001231919-26-000656#line-3","is_derivative":false,"issuer_cik":"0001315082","issuer_name":"Artiva Biotherapeutics, Inc.","issuer_ticker":"ARTV","issuer_name_source":null,"issuer_url":"/issuer/0001315082","owner_cik":null,"owner_name":"Shah Rajeev M.; RA Capital Nexus Fund III, L.P.; RA Capital Nexus Fund, L.P.; Kolchinsky Peter; RA Capital Healthcare Fund LP","owner_display_name":"Shah Rajeev M.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":124893.0,"shares_display":"124,893","price_per_share":8.89,"price_display":"8.89","price_state":"stated","total_value":1110298.77,"total_display":"1,110,298.77","total_whole":"1,110,299","shares_owned_after":16763043.0,"shares_owned_after_display":"16,763,043","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-16","filed_date":"2026-06-16","scope":"insider"},{"id":5838788,"accession":"0001231919-26-000656","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001231919-26-000656","line_url":"/filing/0001231919-26-000656#line-2","is_derivative":false,"issuer_cik":"0001315082","issuer_name":"Artiva Biotherapeutics, Inc.","issuer_ticker":"ARTV","issuer_name_source":null,"issuer_url":"/issuer/0001315082","owner_cik":null,"owner_name":"Shah Rajeev M.; RA Capital Nexus Fund III, L.P.; RA Capital Nexus Fund, L.P.; Kolchinsky Peter; RA Capital Healthcare Fund LP","owner_display_name":"Shah Rajeev M.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15414.0,"shares_display":"15,414","price_per_share":8.99,"price_display":"8.99","price_state":"stated","total_value":138571.86,"total_display":"138,571.86","total_whole":"138,572","shares_owned_after":16638150.0,"shares_owned_after_display":"16,638,150","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-15","filed_date":"2026-06-16","scope":"insider"},{"id":5838782,"accession":"0001231919-26-000656","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231919-26-000656","line_url":"/filing/0001231919-26-000656#line-1","is_derivative":false,"issuer_cik":"0001315082","issuer_name":"Artiva Biotherapeutics, Inc.","issuer_ticker":"ARTV","issuer_name_source":null,"issuer_url":"/issuer/0001315082","owner_cik":null,"owner_name":"Shah Rajeev M.; RA Capital Nexus Fund III, L.P.; RA Capital Nexus Fund, L.P.; Kolchinsky Peter; RA Capital Healthcare Fund LP","owner_display_name":"Shah Rajeev M.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":391019.0,"shares_display":"391,019","price_per_share":8.57,"price_display":"8.57","price_state":"stated","total_value":3351032.83,"total_display":"3,351,032.83","total_whole":"3,351,033","shares_owned_after":16622736.0,"shares_owned_after_display":"16,622,736","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-12","filed_date":"2026-06-16","scope":"insider"},{"id":5909121,"accession":"0001231919-26-000625","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001231919-26-000625","line_url":"/filing/0001231919-26-000625#line-3","is_derivative":false,"issuer_cik":"0001315082","issuer_name":"Artiva Biotherapeutics, Inc.","issuer_ticker":"ARTV","issuer_name_source":null,"issuer_url":"/issuer/0001315082","owner_cik":null,"owner_name":"RA Capital Nexus Fund, L.P.; Kolchinsky Peter; RA Capital Nexus Fund III, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M.","owner_display_name":"RA Capital Nexus Fund, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":548580.0,"shares_display":"548,580","price_per_share":7.91,"price_display":"7.91","price_state":"stated","total_value":4339267.8,"total_display":"4,339,267.80","total_whole":"4,339,268","shares_owned_after":16231717.0,"shares_owned_after_display":"16,231,717","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-11","filed_date":"2026-06-11","scope":"insider"},{"id":5786598,"accession":"0001231919-26-000638","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001231919-26-000638","line_url":"/filing/0001231919-26-000638","is_derivative":false,"issuer_cik":"0001315082","issuer_name":"Parabilis Medicines, Inc.","issuer_ticker":"PBLS","issuer_name_source":null,"issuer_url":"/issuer/0001315082","owner_cik":null,"owner_name":"Shah Rajeev M.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; Kolchinsky Peter","owner_display_name":"Shah Rajeev M.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Voting Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21188750.0,"shares_display":"21,188,750","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":423775000.0,"total_display":"423,775,000.00","total_whole":"423,775,000","shares_owned_after":26285093.0,"shares_owned_after_display":"26,285,093","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-11","filed_date":"2026-06-15","scope":"insider","n_lines":2},{"id":5909119,"accession":"0001231919-26-000625","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001231919-26-000625","line_url":"/filing/0001231919-26-000625#line-2","is_derivative":false,"issuer_cik":"0001315082","issuer_name":"Artiva Biotherapeutics, Inc.","issuer_ticker":"ARTV","issuer_name_source":null,"issuer_url":"/issuer/0001315082","owner_cik":null,"owner_name":"RA Capital Nexus Fund, L.P.; Kolchinsky Peter; RA Capital Nexus Fund III, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M.","owner_display_name":"RA Capital Nexus Fund, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":103.0,"shares_display":"103","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":721.0,"total_display":"721.00","total_whole":"721","shares_owned_after":15683137.0,"shares_owned_after_display":"15,683,137","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-10","filed_date":"2026-06-11","scope":"insider"},{"id":5909116,"accession":"0001231919-26-000625","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231919-26-000625","line_url":"/filing/0001231919-26-000625#line-1","is_derivative":false,"issuer_cik":"0001315082","issuer_name":"Artiva Biotherapeutics, Inc.","issuer_ticker":"ARTV","issuer_name_source":null,"issuer_url":"/issuer/0001315082","owner_cik":null,"owner_name":"RA Capital Nexus Fund, L.P.; Kolchinsky Peter; RA Capital Nexus Fund III, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M.","owner_display_name":"RA Capital Nexus Fund, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":479039.0,"shares_display":"479,039","price_per_share":6.91,"price_display":"6.91","price_state":"stated","total_value":3310159.49,"total_display":"3,310,159.49","total_whole":"3,310,159","shares_owned_after":15683034.0,"shares_owned_after_display":"15,683,034","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-09","filed_date":"2026-06-11","scope":"insider"},{"id":6237675,"accession":"0001231919-26-000491","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231919-26-000491","line_url":"/filing/0001231919-26-000491#line-1","is_derivative":false,"issuer_cik":"0001315082","issuer_name":"Artiva Biotherapeutics, Inc.","issuer_ticker":"ARTV","issuer_name_source":null,"issuer_url":"/issuer/0001315082","owner_cik":null,"owner_name":"RA Capital Nexus Fund, L.P.; Kolchinsky Peter; RA Capital Healthcare Fund LP; Shah Rajeev M.; RA Capital Nexus Fund III, L.P.","owner_display_name":"RA Capital Nexus Fund, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6510416.0,"shares_display":"6,510,416","price_per_share":11.52,"price_display":"11.52","price_state":"stated","total_value":74999992.32,"total_display":"74,999,992.32","total_whole":"74,999,992","shares_owned_after":15203995.0,"shares_owned_after_display":"15,203,995","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-11","filed_date":"2026-05-13","scope":"insider"},{"id":6042425,"accession":"0001231919-26-000300","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001231919-26-000300","line_url":"/filing/0001231919-26-000300#line-2","is_derivative":false,"issuer_cik":"0001315082","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001315082","owner_cik":null,"owner_name":"RA Capital Healthcare Fund LP; Kolchinsky Peter; RA Capital Nexus Fund III, L.P.; Shah Rajeev M.","owner_display_name":"RA Capital Healthcare Fund LP","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":58300.0,"shares_display":"58,300","price_per_share":24.16,"price_display":"24.16","price_state":"stated","total_value":1408528.0,"total_display":"1,408,528.00","total_whole":"1,408,528","shares_owned_after":5825521.0,"shares_owned_after_display":"5,825,521","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-03-30","filed_date":"2026-03-31","scope":"insider"},{"id":6042419,"accession":"0001231919-26-000300","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231919-26-000300","line_url":"/filing/0001231919-26-000300#line-1","is_derivative":false,"issuer_cik":"0001315082","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001315082","owner_cik":null,"owner_name":"RA Capital Healthcare Fund LP; Kolchinsky Peter; RA Capital Nexus Fund III, L.P.; Shah Rajeev M.","owner_display_name":"RA Capital Healthcare Fund LP","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":310700.0,"shares_display":"310,700","price_per_share":23.67,"price_display":"23.67","price_state":"stated","total_value":7354269.0,"total_display":"7,354,269.00","total_whole":"7,354,269","shares_owned_after":5767221.0,"shares_owned_after_display":"5,767,221","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-03-27","filed_date":"2026-03-31","scope":"insider"},{"id":5799516,"accession":"0001231919-26-000231","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231919-26-000231","line_url":"/filing/0001231919-26-000231#line-1","is_derivative":false,"issuer_cik":"0001315082","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0001315082","owner_cik":null,"owner_name":"RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; Shah Rajeev M.; Kolchinsky Peter","owner_display_name":"RA Capital Healthcare Fund LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300000.0,"shares_display":"300,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":4800000.0,"total_display":"4,800,000.00","total_whole":"4,800,000","shares_owned_after":4603418.0,"shares_owned_after_display":"4,603,418","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-26","filed_date":"2026-03-02","scope":"insider"},{"id":6137404,"accession":"0001231919-26-000135","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001231919-26-000135","line_url":"/filing/0001231919-26-000135","is_derivative":false,"issuer_cik":"0001315082","issuer_name":"SpyGlass Pharma, Inc.","issuer_ticker":"SGP","issuer_name_source":null,"issuer_url":"/issuer/0001315082","owner_cik":null,"owner_name":"RA Capital Nexus Fund III, L.P.; Kolchinsky Peter; RA Capital Healthcare Fund LP; Shah Rajeev M.","owner_display_name":"RA Capital Nexus Fund III, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3690000.0,"shares_display":"3,690,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":59040000.0,"total_display":"59,040,000.00","total_whole":"59,040,000","shares_owned_after":5966439.0,"shares_owned_after_display":"5,966,439","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-09","filed_date":"2026-02-11","scope":"insider","n_lines":2},{"id":5965432,"accession":"0001231919-26-000018","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231919-26-000018","line_url":"/filing/0001231919-26-000018#line-1","is_derivative":false,"issuer_cik":"0001315082","issuer_name":"Climb Bio, Inc.","issuer_ticker":"CLYM","issuer_name_source":null,"issuer_url":"/issuer/0001315082","owner_cik":null,"owner_name":"RA Capital Nexus Fund, L.P.; Kolchinsky Peter; RA Capital Nexus Fund III, L.P.; RA Capital Nexus Fund II, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M.","owner_display_name":"RA Capital Nexus Fund, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7111.0,"shares_display":"7,111","price_per_share":3.5,"price_display":"3.50","price_state":"stated","total_value":24888.5,"total_display":"24,888.50","total_whole":"24,889","shares_owned_after":3403429.0,"shares_owned_after_display":"3,403,429","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-07","scope":"insider"},{"id":4944278,"accession":"0001231919-25-000616","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001231919-25-000616","line_url":"/filing/0001231919-25-000616#line-3","is_derivative":false,"issuer_cik":"0001315082","issuer_name":"Climb Bio, Inc.","issuer_ticker":"CLYM","issuer_name_source":null,"issuer_url":"/issuer/0001315082","owner_cik":null,"owner_name":"RA Capital Nexus Fund, L.P.; Kolchinsky Peter; RA Capital Nexus Fund II, L.P.; Shah Rajeev M.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.","owner_display_name":"RA Capital Nexus Fund, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":101462.0,"shares_display":"101,462","price_per_share":2.86,"price_display":"2.86","price_state":"stated","total_value":290181.32,"total_display":"290,181.32","total_whole":"290,181","shares_owned_after":3396318.0,"shares_owned_after_display":"3,396,318","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-12","filed_date":"2025-12-15","scope":"insider"},{"id":4944274,"accession":"0001231919-25-000616","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001231919-25-000616","line_url":"/filing/0001231919-25-000616#line-2","is_derivative":false,"issuer_cik":"0001315082","issuer_name":"Climb Bio, Inc.","issuer_ticker":"CLYM","issuer_name_source":null,"issuer_url":"/issuer/0001315082","owner_cik":null,"owner_name":"RA Capital Nexus Fund, L.P.; Kolchinsky Peter; RA Capital Nexus Fund II, L.P.; Shah Rajeev M.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.","owner_display_name":"RA Capital Nexus Fund, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":213099.0,"shares_display":"213,099","price_per_share":2.18,"price_display":"2.18","price_state":"stated","total_value":464555.82,"total_display":"464,555.82","total_whole":"464,556","shares_owned_after":3294856.0,"shares_owned_after_display":"3,294,856","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-11","filed_date":"2025-12-15","scope":"insider"},{"id":5120540,"accession":"0001231919-25-000547","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001231919-25-000547","line_url":"/filing/0001231919-25-000547","is_derivative":false,"issuer_cik":"0001315082","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001315082","owner_cik":null,"owner_name":"RA Capital Nexus Fund, L.P.; Kolchinsky Peter; RA Capital Nexus Fund III, L.P.; Shah Rajeev M.; RA Capital Healthcare Fund LP","owner_display_name":"RA Capital Nexus Fund, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25183.0,"shares_display":"25,183","price_per_share":39.5,"price_display":"39.50","price_state":"stated","total_value":994728.5,"total_display":"994,728.50","total_whole":"994,729","shares_owned_after":650307.0,"shares_owned_after_display":"650,307","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-21","filed_date":"2025-11-24","scope":"insider","n_lines":4},{"id":5120521,"accession":"0001231919-25-000547","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001231919-25-000547","line_url":"/filing/0001231919-25-000547","is_derivative":false,"issuer_cik":"0001315082","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001315082","owner_cik":null,"owner_name":"RA Capital Nexus Fund, L.P.; Kolchinsky Peter; RA Capital Nexus Fund III, L.P.; Shah Rajeev M.; RA Capital Healthcare Fund LP","owner_display_name":"RA Capital Nexus Fund, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5133.0,"shares_display":"5,133","price_per_share":40.12767777128385,"price_display":"40.13","price_state":"stated","total_value":205975.37,"total_display":"205,975.37","total_whole":"205,975","shares_owned_after":661019.0,"shares_owned_after_display":"661,019","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-20","filed_date":"2025-11-24","scope":"insider","n_lines":8}],"collapsed":true,"next_cursor":"2025-11-20|5120487","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001984086","name":"Septerna, Inc.","url":"/issuer/0001984086","role":"Director","n_filings":2,"first_seen":"2024-10-30","last_seen":"2026-08-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001817241","name":"Artiva Biotherapeutics, Inc.","url":"/issuer/0001817241","role":"Director","n_filings":11,"first_seen":"2024-07-24","last_seen":"2026-07-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001657677","name":"Parabilis Medicines, Inc.","url":"/issuer/0001657677","role":"Director","n_filings":2,"first_seen":"2026-06-15","last_seen":"2026-07-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001933414","name":"Mineralys Therapeutics, Inc.","url":"/issuer/0001933414","role":"Director","n_filings":4,"first_seen":"2023-02-16","last_seen":"2026-03-31"},{"type":"issuer","type_label":"ISSUER","cik":"0002023658","name":"Bicara Therapeutics Inc.","url":"/issuer/0002023658","role":"Director","n_filings":2,"first_seen":"2024-09-18","last_seen":"2026-03-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001778922","name":"SpyGlass Pharma, Inc.","url":"/issuer/0001778922","role":"Director","n_filings":1,"first_seen":"2026-02-11","last_seen":"2026-02-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001768446","name":"Climb Bio, Inc.","url":"/issuer/0001768446","role":"Director, Ten percent owner","n_filings":3,"first_seen":"2024-07-01","last_seen":"2026-01-07"},{"type":"issuer","type_label":"ISSUER","cik":"0002036042","name":"Sionna Therapeutics, Inc.","url":"/issuer/0002036042","role":"Director","n_filings":4,"first_seen":"2025-02-10","last_seen":"2025-11-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001883840","retrieved_at":"2026-08-24T22:30:21+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}